• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Indian drug firms top filings with USFDA

      Posted AtBusiness-standard.com

      Indian pharma companies have filed the maximum number of drug master filings (DMFs) to the US Food and Drug Administration (US FDA) in October-December 2007 quarter.

      The total number of DMFs filed to the US FDA in the last quarter was 187, Indian companies alone filing for 89 DMFs, according to data gathered from analysts and industry sources. Indian DMFs filing accounting for 47.6 per cent of the total DMFs filed in the last quarter.

      DMFs are confidential, proprietary assets that present to the US FDA the formulae, processes, test methodology, and other data relevant to the manufacture of products used in the composition, packaging and processing of pharmaceuticals or biologics. DMFs filings from the Chinese pharma players to the US FDA amounted to less than 20.

      Amongst the Indian pharma players, Ranbaxy has filed 13 DMFs to the US FDA in the last quarter, while both Dr Reddy’s and Aurobindo Pharma filed 10 DMFs, add analysts.

      Ranbaxy is understood to have filed a DMF for cilastatin to the US FDA in the last quarter. Analysts say Cilastatin is not a drug in itself, it is administered along with the antibiotic imipenem, to prevent the latter from being inactivated by the enzyme dehydropeptidase.

      May 14, 2009


       

      Share this Article!

    Back to top^